You have 9 free searches left this month | to do more
Showing 1 - 25 of
578 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
2022-03-28
Mar 28, 2022
C
Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +3 more
  • Duarte, California
    City of Hope Medical Center
2022-02-17
Feb 17, 2022
N
Suspended
  • Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-04-05
Apr 5, 2022
M
Recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Decitabine
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-04
Mar 4, 2022
C
Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-02-28
Feb 28, 2022
T
Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Decitabine plus Penpulimab
  • (no location specified)
2022-02-23
Feb 23, 2022
E
Recruiting
  • Sickle Cell Disease
  • Chicago, Illinois
    University of Illinois at Chicago College of Medicine
2022-03-21
Mar 21, 2022
N
Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-03-31
Mar 31, 2022
C
Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-02-08
Feb 8, 2022
T
Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
2021-09-23
Sep 23, 2021
U
Active, not recruiting
  • Acute Myelogenous Leukemia
  • Decitabine
  • Rochester, New York
    University of Rochester
2021-12-08
Dec 8, 2021
A
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Bratislava, Slovakia
    Summit Clinical Research s.r.o
2022-01-21
Jan 21, 2022
M
Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-01-13
Jan 13, 2022
A
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Bratislava, Slovakia
    Summit Clinical Research s.r.o
2022-01-21
Jan 21, 2022
V
Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
2021-12-03
Dec 3, 2021
S
Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2022-02-04
Feb 4, 2022
I
Recruiting
  • Hodgkin Lymphoma, Adult
  • +2 more
  • PD-1 inhibitor
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
2021-12-14
Dec 14, 2021
J
Recruiting
  • COVID-19
  • Decitabine
  • Placebo Saline
  • Baltimore, Maryland
    Johns Hopkins University
2022-02-07
Feb 7, 2022
C
Recruiting
  • Childhood Solid Tumor
  • +5 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2022-02-13
Feb 13, 2022
C
Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-03-09
Mar 9, 2022
I
Recruiting
  • Refractory Aplastic Anemia
  • Decitabine
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
2021-05-10
May 10, 2021
U
Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
2021-10-05
Oct 5, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Decitabine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-25
Feb 25, 2022
W
Active, not recruiting
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Decitabine
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-02-18
Feb 18, 2022
U
Recruiting
  • PTCL
  • CTCL
  • Charlottesville, Virginia
    University of Virginia
2022-02-10
Feb 10, 2022